- Report
- February 2021
- 500 Pages
United States
From €2305EUR$2,400USD£1,985GBP
- Report
- May 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,191GBP
Rosiglitazone is a drug used to treat endocrine and metabolic disorders. It is a member of the thiazolidinedione class of drugs, which are used to treat type 2 diabetes. Rosiglitazone works by increasing the body's sensitivity to insulin, which helps to lower blood sugar levels. It is usually prescribed in combination with other diabetes medications, such as metformin or sulfonylureas. It is also used to treat polycystic ovary syndrome and can be used off-label to treat other conditions, such as obesity and non-alcoholic fatty liver disease.
Rosiglitazone is available in both generic and brand-name formulations. Common brand names include Avandia, Avandamet, and Avandaryl. It is available in tablet form and is usually taken once or twice daily.
Companies in the Rosiglitazone market include GlaxoSmithKline, Merck, and Takeda Pharmaceuticals. Show Less Read more